PyloPlus UBT System

FDA Premarket Approval P170022

Pre-market Approval Supplement Details

Approval of the pyloplus ubt. The pyloplus ubt system is intended for use in the qualitative detection of urease associated with h. Pylori in the human stomach and is indicated as an aid in the initial diagnosis of h. Pylori infection in adults 18 years old and older. The pyloplus ubt system consists of the pyloplus ubt kit and the pyloplus ubt analyzer. The analyzer is an infrared spectrometer used for the measurement of the ratio of 13co2 to 12co2 in breath samples. The pyloplus ubt system is for use by trained health care professionals as prescribed by a physician.

DevicePyloPlus UBT System
Generic NameTest, Urea Adult And Pediatric (breath),
ApplicantARJ Medical Inc.
Date Received2017-07-26
Decision Date2020-02-18
PMAP170022
SupplementS
Product CodeOZA 
Advisory CommitteeMicrobiology
Expedited ReviewNo
Combination Product Yes
Applicant Address ARJ Medical Inc. 209 State Street E oldsmar, FL 34677

Supplemental Filings

Supplement NumberDateSupplement Type
P170022Original Filing
S001 2022-05-04 Real-time Process

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.